
Bradley Peterson, MD, discusses when pediatricians should consider adding a second treatment for pediatric anxiety and why improvement may continue well beyond the first 3 months of therapy.

Bradley Peterson, MD, Chief, Division of Psychiatry; Co-Director, Behavioral Health Institute; Chair in Child and Adolescent Psychiatry, Children’s Hospital Los Angeles
Chief, Division of Child and Adolescent Psychiatry; Vice Chair for Research, Department of Psychiatry; Professor of Pediatrics with Tenure, Keck School of Medicine of USC

Bradley Peterson, MD, discusses when pediatricians should consider adding a second treatment for pediatric anxiety and why improvement may continue well beyond the first 3 months of therapy.

Bradley Peterson, MD, discusses how treatment preferences, access, tolerability, and patient characteristics can guide pediatric anxiety care when CBT and medication provide similar overall benefits.

CBT and fluoxetine both reduced pediatric anxiety, while starting with CBT before adding medication showed advantages on several outcomes.

September 10th 2026

September 5th 2026